Rare Skin Blistering Condition Gets First Drug Approved

(MedPage Today) -- Credit: B.E.L.A. butterfly children The FDA granted the first drug approval for dystrophic epidermolysis bullosa (DEB), a topical gene therapy that treats the blistering wounds it causes, the agency announced Friday. The...
Source: MedPage Today Public Health - Category: American Health Source Type: news